US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy
I'm PortAI, I can summarize articles.
Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's ( MRK ) cholesterol pill and its cancer therapy, making them the latest additions to the fast-track program. (Reporting by Siddhi Mahatole and Mariam Sunny in Bengaluru; Editing by Leroy Leo and Shailesh Kuber)
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments